Rentokil Initial PLC
19 December 2005
19 December 2005
RENTOKIL INITIAL plc ADDRESSES PENSION SCHEME DEFICIT
In its third quarter update on 3 November 2005, Rentokil Initial plc ('the
Company') announced that it was in discussions with the Trustees of the Defined
Benefit (DB) Sections of the Rentokil Initial Pension Scheme ('the Scheme')
regarding measures to address the Scheme's funding deficit and to ensure
appropriate future funding levels. These discussions have resulted in the
company proposing a series of positive steps which will deal with these issues
and protect the security of the Scheme's benefits for its members.
The deficit of the UK Scheme under IAS 19 as at 30 November 2005 was estimated
to be £325 million. In response to a general trend of increasing longevity,
which has adversely impacted the Scheme, the Company and Trustees have agreed to
a more prudent basis for estimating longevity that will increase this deficit by
an additional £24 million. An agreement has been reached between the Company
and the Trustees to make an immediate payment of £200 million, with the
remaining deficit being met by a series of payments ending no later than January
2012. The changed regulatory environment for pensions requires the Company to
deal with these issues in a shorter timescale than it might otherwise have done.
The total funding required to address the deficit will be in the range of £370
million to £380 million depending on the final timing of the payments.
In order to reduce the likelihood that the scheme deficit will increase
materially in the future, following discussions with the Company, the Trustees
will be reviewing the Scheme's investment strategy, with the aim of reducing
potential volatility that might be caused by market movements. This will result
in a lower exposure to equities over time and improve the security of Scheme
benefits.
With immediate effect, the Company will be entering into a period of
comprehensive consultation with active members of the DB Sections of the Scheme.
The Company is proposing to close the DB Sections for the future accrual of
benefits for active members. The aim of this is to reduce exposure to future
shortfalls and to ensure that the Scheme will be in a position to continue to
pay all benefits that have been earned to date by its members. It will also
provide the Company with more predictable costs of future pension provision.
The proposed closure will have no impact on the scheme's deferred pensioners and
pensions in payment.
If the Company's proposals are implemented, existing active members of the
Scheme's DB Sections will be offered membership in a defined contribution
arrangement so that they can continue to make provision for retirement.
Final decisions regarding the review will be taken once the consultation period
with active members has been completed later in 2006.
Shareholder/analyst enquiries
Andrew Macfarlane, CFO Tel: 01342 833022
Lisa Williams, Investor Relations Tel: 01342 833022
Media enquiries
Charles Grimaldi, Corporate Affairs Director Tel: 01342 833022
Gill Ackers/Kate Miller, Brunswick Group LLP Tel: 020 7404 5959
Notes to editors:
The Defined Benefit Sections of the Rentokil Initial Pension Scheme currently
has 3,000 active members, 15,000 deferred pensioners and 8,000 pensions in
payment.
At 30 November 2005, the scheme had assets of £640 million and liabilities of
£965 million.
In the Lane Clark Peacock Accounting for Pensions Annual Survey 2005, Rentokil
Initial had the 96th lowest level of pension scheme funding out of the FTSE-100.
This information is provided by RNS
The company news service from the London Stock Exchange KBDDQBD
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.